Sjs Investment Consulting Inc. Bausch Health Companies Inc. Transaction History
Sjs Investment Consulting Inc.
- $499 Million
- Q2 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 30 shares of BHC stock, worth $189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$189% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
275Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$219 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$167 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$142 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$122 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$99 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.29B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...